Clicky

Rakovina Therapeutics Inc(RKV) News

Date Title
Jun 6 Rakovina Therapeutics Announces the Closing of Oversubscribed Private Placement of $4.9 Million
Jun 2 Rakovina Therapeutics Announces 2025 Q1 Financial Results and Provides Corporate Update
May 28 Rakovina Announces Debentureholder Election to Receive Shares in Partial Satisfaction of Debenture Interest Payment Obligations
Apr 22 Rakovina Therapeutics Congratulates Scientific Advisor Dr. Artem Cherkasov on Global Recognition for Breakthrough AI Innovation in Drug Discovery
Mar 12 Rakovina's AI-driven Anti-Cancer Compounds in Pre-clinical Testing
Mar 12 Next-Gen Cancer Treatment: Rakovina’s AI-Driven ATR Inhibitors Enter Preclinical Testing
Jul 27 Rakovina Therapeutics Closes Previously Announced Over-subscribed Private Placement
Jun 20 Rakovina Therapeutics Announces Oversubscribed Private Placement and Results from 2024 Annual General Meeting